Azabicycloalkane compounds

Details Azabicycloalkane compounds Azabicycloalkane compounds

2008-02-07

2010-06-08

Andres, Janet L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S233500, C514S233800, C514S241000, C514S252040, C514S269000, C514S302000, C514S304000, C544S061000, C544S127000, C544S180000, C544S238000, C544S335000, C546S089000, C546S097000, C546S124000, C546S125000, C546S126000, C546S127000

Reexamination Certificate

active

07732441

ABSTRACT:
This invention provides compounds of formula I:wherein R1, R2, R3, R4, R5, R6and R7are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β2adrenergic receptor agonist and muscarinic receptor antagonist activity. Such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

REFERENCES:
patent: 3505337 (1970-04-01), Zeile et al.
patent: 4026897 (1977-05-01), Nakagawa et al.
patent: 4460581 (1984-07-01), Schromm et al.
patent: 4894219 (1990-01-01), Baker et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6362371 (2002-03-01), Moran et al.
patent: 6433027 (2002-08-01), Bozung et al.
patent: 6455524 (2002-09-01), Bozung et al.
patent: 6541669 (2003-04-01), Moran et al.
patent: 6576793 (2003-06-01), Moran et al.
patent: 6593497 (2003-07-01), Choi et al.
patent: 6653323 (2003-11-01), Moran et al.
patent: 6670376 (2003-12-01), Moran et al.
patent: 6693202 (2004-02-01), Aggen et al.
patent: 6713651 (2004-03-01), Moran et al.
patent: 6747043 (2004-06-01), Moran et al.
patent: 2002/0111363 (2002-08-01), Drechsel et al.
patent: 2002/0115681 (2002-08-01), Bozung et al.
patent: 2003/0018019 (2003-01-01), Meade et al.
patent: 2003/0055080 (2003-03-01), Fomer et al.
patent: 2004/0167167 (2004-08-01), Mammen et al.
patent: 2004/0209860 (2004-10-01), Mammen et al.
patent: 2004/0209915 (2004-10-01), Mammen et al.
patent: 0 418 716 (1991-03-01), None
patent: WO 99/64031 (1999-12-01), None
patent: WO 99/64035 (1999-12-01), None
patent: WO 99/64043 (1999-12-01), None
patent: WO 01/04118 (2001-01-01), None
patent: WO 02/051841 (2002-07-01), None
patent: WO 02/053564 (2002-07-01), None
patent: WO 02/066422 (2002-08-01), None
patent: WO 03/053966 (2003-07-01), None
patent: WO 03/087096 (2003-10-01), None
patent: WO 2004/048373 (2004-06-01), None
patent: WO 2004/089892 (2004-10-01), None
Barnes, “Tiotropium bromide”, Exp. Opin. Invest. Drugs. 10(4), pp. 733-740 (2001).
Zlotos et al., “Muscarinic receptor agonists and antagonists”, Exp. Opin. Ther. Patents, 9(8), pp. 1029-1053 (1999).

Affiliated with

Also associated with

Rating

Azabicycloalkane compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azabicycloalkane compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicycloalkane compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4249649